MarginsXMarginsX
Home › Markets › Health Care › NSPR

InspireMD Inc. (NSPR)

NSPR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6000
-6.85% on the day
Market cap
$28.1M
Nano cap
Revenue · 2025
$9.0M
+28.1% on 2024
Net income · 2025
-$48.8M
-543.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1433607/000149315226010886/0001493152-26-010886-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNSPR on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001433607
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$9.0M
Net income-$48.8M
Operating income-$49.6M
Net margin-543.3%
Operating margin-552.6%
Revenue growth+28.1%
Cash$8.9M
Total assets$69.4M
P/E (computed)Net income was not positive
P/S (computed)3.1×

Warning signs

Cash runway
4.4 months
$15.1M cash at June 30, 2026
Share count, 1 year
+11.4%
2025-08-04 to 2026-08-14 · +119.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$303K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Therefore, there is substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-08-14
Cash and burn$15.1M cash; operating cash flow -$10.3M a quarter.Report 2026-06-30
Shares outstanding46,489,118 (2026-08-14); 41,720,662 a year earlier; 21,195,103 three years earlier.Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-11-12
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-07-23
AuditorKesselman & Kesselman C.P.A.s, Tel-Aviv, IsraelPCAOB Form AP 2026-03-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $430K, sold $127K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$1.8M-$14.3M-$10.9M$15.1MNo debt tags$10.8M10-Q 2026-08-14
Q1 2026
2026-03-31
$3.4M-$13.7M-$12.3M$11.4MNo debt tags$10.8M10-Q 2026-05-07
Q4 2025
2025-12-31
$3.1M-$11.8M-$9.3M$8.9MNo debt tags$9.0M10-K 2026-03-18
Q3 2025
2025-09-30
$2.5M-$12.7M-$8.6M$63.4MNo debt tags$7.8M10-Q 2025-11-10
Q2 2025
2025-06-30
$1.8M-$13.2M-$8.3M$11.5MNo debt tags$7.1M10-Q 2026-08-14
Q1 2025
2025-03-31
$1.5M-$11.2M-$8.8M$12.4MNo debt tags$7.0M10-Q 2026-05-07
Q4 2024
2024-12-31
$1.9M-$9.2M-$6.8M$18.9MNo debt tags$7.0M10-K 2026-03-18
Q3 2024
2024-09-30
$1.8M-$7.9M-$5.7M$15.8MNo debt tags$6.8M10-Q 2025-11-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-11-16
Latest annual report10-K2026-03-18
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-8.6%
1 month+28.0%
3 months-23.8%
Year to date-64.0%
1 year-65.8%
From 52-week high-70.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
XTNTXtant Medical Holdings Inc.$0.2098-22.78%$29.4M
PLRZPolyrizon Ltd.$10.70-2.37%$26.0M
DAVIDavion Healthcare Plc$1.02+2.00%$25.5M
NEPHNephros Inc.$3.00-1.64%$32.6M
TELATELA Bio Inc.$0.7616-7.13%$34.4M
BEATHeartbeam Inc.$0.3590-9.23%$22.7M
SRTSSensus Healthcare Inc.$2.34+0.65%$38.5M
MDAISpectral AI Inc.$1.31+0.77%$42.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier